COMMUNIQUÉS West-GlobeNewswire

Natus Medical Comments on ISS Report
11/06/2018
Board Urges Shareholders to Vote on the WHITE Proxy Card FOR the Election of Doris Engibous and Robert Weiss ISS Agrees Shareholders Should NOT Vote for Removal of Chairman Robert Gunst PLEASANTON, Calif. , June 11, [...]
International Endeavors Corporation Hires Marketing Director
11/06/2018
TEMECULA, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation (OTC:IDVV) announces the hiring of William Vinson as Marketing Director to expand sales of the Off Grid Grow Lab [...]
Lexington Biosciences Announces Amended Terms to Previously Announced Brokered Financing
11/06/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, June 11, 2018 (GLOBE NEWSWIRE [...]
Study published in Cancer Discovery Indicates that NY-ESO SPEAR T-cells are Long-lived, Self‑renewing, and Capable of Persistent Anti-Tumor Effects
11/06/2018
Data indicate that self-renewing pools of SPEAR T-cells can produce a continuous supply of effector cells capable of mediating sustained antitumor effects PHILADELPHIA and OXFORD, United Kingdom, June 11, 2018 (GLOBE [...]
Eyenovia to Present at the JMP Securities 2018 Life Sciences Conference
11/06/2018
NEW YORK, June 11, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to [...]
VIVUS Executes on its Strategic Vision with the Closing of its Acquisition of PANCREAZE® and Previously Announced Financing Transaction
11/06/2018
CAMPBELL, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the “Company”), a biopharmaceutical company, today announced that it has met the closing conditions, including Hart-Scott-Rodino review, [...]
MPX Completes Acquisition of Canadian Licensed Producer
11/06/2018
TORONTO, June 11, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that it has successfully completed the acquisition of 100% of the issued [...]
Summit Unveils Second Novel Target for Gonorrhoea at ASM Microbe 2018
11/06/2018
Highlights the Power of the Discuva Platform to Identify Novel Antibiotic Targets OXFORD, United Kingdom and CAMBRIDGE, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) announces [...]
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Year-end Financial Results on June 15, 2018
11/06/2018
Financials for Fiscal Year 2018 Ended March 31, 2018 will be released on June 14, 2018 NORTHVALE, N.J., June 11, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty [...]
Global campaign during 10th annual National Blood Donor Week highlights need for blood
11/06/2018
44,000 blood donors needed across the country by Canada Day OTTAWA, June 11, 2018 (GLOBE NEWSWIRE) -- Canadian Blood Services is getting ready to support patients this summer and is inviting Canadians to participate in [...]
Une campagne internationale et la dixième Semaine nationale du don de sang attirent l’attention sur les besoins en sang
11/06/2018
Nous avons besoin de 44 000 donneurs d’ici la fête du Canada OTTAWA, 11 juin 2018 (GLOBE NEWSWIRE) -- Pour pouvoir répondre aux besoins des patients cet été, la Société canadienne du sang invite la population à [...]
International Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson's Disease Clinical Trial
11/06/2018
CARLSBAD, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]
MediWound Completes Enrollment in NexoBrid® U.S. Phase 3 DETECT Study
11/06/2018
Top-line acute data currently expected around year end 2018 YAVNE, Israel, June 11, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to [...]
Neuralstem Awarded Phase I SBIR Contract to Support Research into Neural Stem Cell Therapy for Severe Traumatic Brain Injury
11/06/2018
GERMANTOWN, Md., June 11, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that it has been awarded a Phase I [...]
Transactions under Novozymes’ stock buyback program
11/06/2018
Please read the full announcement in the attached PDF Attachment 2018_38_Stock_Buybackprogram_EN
Novo Nordisk A/S - Share repurchase programme
11/06/2018
Bagsværd, Denmark, 11 June 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
Tetraphase Pharmaceuticals Announces Data from a Pooled Analysis of IGNITE1 and IGNITE4 Phase 3 Trials Evaluating Eravacycline in Complicated Intra-Abdominal Infections at the ASM Microbe 2018 Annual Meeting
11/06/2018
Eravacycline Global Surveillance and TP-6076 Data Also Highlighted WATERTOWN, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing [...]
Dynavax to Present at the William Blair 38th Annual Growth Stock Conference
11/06/2018
BERKELEY, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) today announced that Michael Ostrach, Dynavax’s Chief Financial Officer, will present at the William Blair 38th Annual [...]
Vical Reports Phase 2 Trial of HSV-2 Therapeutic Vaccine Did Not Meet Primary Endpoint
11/06/2018
Company to focus on advancing VL-2397 and other pipeline opportunities SAN DIEGO, June 11, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced top-line results from a randomized, double-blind, [...]

Pages